Literature DB >> 11435923

Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt.

L Zhang1, D R Rubinow, G Xaing , B S Li, Y H Chang, D Maric, J L Barker, W Ma.   

Abstract

The cellular mechanisms underlying the neuroprotective effects of estrogen are only beginning to be elucidated. Here we examined the role of protein kinase B (Akt) activation in 17beta-estradiol (E2) inhibition of beta-amyloid peptide (31-35) (Abeta31-35)-induced neurotoxicity in cultured rat hippocampal neurons. Abeta31-35 (25-30 betaM) significantly decreased the total number of microtubule associated protein-2 positive cells (MAP2+). This decrease was significantly reversed by pre-treatment with 100 nM E2. Further, 100 nM E2 alone significantly increased the total number of protein kinase B and microtubule associated protein-2 positive cells compared with controls. Such E2-induced increases were inhibited by LY294002 (20 microM), a specific PI3-K inhibitor, as well as by tamoxifen, an estrogen receptor antagonist/selective estrogen receptor modulator. These results indicate that the neuroprotective effects of E2 may be mediated at least in part via estrogen receptor-mediated protein kinase B activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435923     DOI: 10.1097/00001756-200107030-00030

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.

Authors:  Hai-Rong Shi; Ling-Qiang Zhu; Shao-Hui Wang; Xin-An Liu; Qing Tian; Qi Zhang; Qun Wang; Jian-Zhi Wang
Journal:  J Neural Transm (Vienna)       Date:  2008-01-24       Impact factor: 3.575

Review 2.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

3.  Mechanism of okadaic acid-induced neuronal death and the effect of estrogens.

Authors:  Kun Don Yi; Douglas F Covey; James W Simpkins
Journal:  J Neurochem       Date:  2008-11-28       Impact factor: 5.372

Review 4.  Progesterone-estrogen interactions in synaptic plasticity and neuroprotection.

Authors:  M Baudry; X Bi; C Aguirre
Journal:  Neuroscience       Date:  2012-11-07       Impact factor: 3.590

5.  Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes.

Authors:  Pratap Karki; Anton Webb; Abdelbassat Zerguine; Joseph Choi; Deok-Soo Son; Eunsook Lee
Journal:  Glia       Date:  2014-04-29       Impact factor: 7.452

Review 6.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

7.  Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.

Authors:  S-Y Park; C Tournell; R C Sinjoanu; A Ferreira
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

8.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

9.  17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention.

Authors:  Liqin Zhao; Jia Yao; Zisu Mao; Shuhua Chen; Yan Wang; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2010-01-06       Impact factor: 4.673

10.  Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.

Authors:  George Notas; Marilena Kampa; Vassiliki Pelekanou; Maria Troullinaki; Yves Jacquot; Guy Leclercq; Elias Castanas
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.